We found that DIM significantly inhibits gastric cancer cell growth in a dose-dependent manner with G1-phase cell cycle arrest by reducing the levels of the cyclin dependent kinase (CDK) 2, CDK4, CDK6, and Cyclin D1 proteins. The gene discussed is CDK4; the disease is gastric cancer.